We want to check chromotin conformation changes and chromotin accesiblility. We also want to compare gene profile with and without indusilam resistant tumors in mouse genetic model
the transcriptomic and epigenetic map of ADRN and MES types of neuroblastomas using murine models treated with indisulam, a selective RBM39 degrade. Overall design: The TH-MYCN/ALKF1178L mice were treated with vehicle or 25mg/kg of indisulam for 3  weeks in our study. The tumor samples were harvested and processed through 10X Single Cell MultiOME ATAC+Gene expression kit.